| P50 | author | Helgi B. Schiöth | Q30112644 |
| P2093 | author name string | Anna Blomqvist | |
| | Anna M S Kindlundh-Högberg | |
| | Rana Malki | |
| P2860 | cites work | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 |
| | Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain | Q28188520 |
| | Localization of neuronal and glial glutamate transporters | Q28238076 |
| | Molecular pharmacology of glutamate transporters, EAATs and VGLUTs | Q28267974 |
| | Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion | Q28585256 |
| | Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations | Q29304271 |
| | The functional anatomy of basal ganglia disorders | Q29617461 |
| | What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? | Q29618655 |
| | Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex | Q29619998 |
| | Memory and Addiction | Q30058617 |
| | Subjective reports on the effects of the MDMA ('ecstasy') experience in humans. | Q51120015 |
| | Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. | Q51584375 |
| | Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. | Q51584922 |
| | Chronic ethanol-mediated up-regulation of the N-methyl-D-aspartate receptor polypeptide subunits in mouse cortical neurons in culture | Q71143737 |
| | Chronic ethanol treatment differentially regulates NMDA receptor subunit mRNA expression in rat brain | Q72285865 |
| | Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo | Q72396411 |
| | Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021 | Q73207610 |
| | Expression of NR1, NR2A-D, and NR3 subunits of the NMDA receptor in the cerebral cortex and olfactory bulb of adult rat | Q73405617 |
| | MDMA induced dopamine release in vivo: role of endogenous serotonin | Q73458370 |
| | Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems | Q77371245 |
| | Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals | Q81459764 |
| | Differential regulation of nuclear receptors, neuropeptides and peptide hormones in the hypothalamus and pituitary of food restricted rats | Q31142509 |
| | A glutamatergic deficiency model of schizophrenia | Q33598404 |
| | Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens | Q33667218 |
| | Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. | Q33692842 |
| | Glutamate-mediated transmission, alcohol, and alcoholism | Q33952973 |
| | Cerebral hemisphere regulation of motivated behavior | Q34105802 |
| | The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 |
| | Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission | Q34400155 |
| | Memory deficits associated with recreational use of "ecstasy" (MDMA). | Q34491716 |
| | NMDA receptor subunits: function and pharmacology. | Q34579640 |
| | Altered states: the clinical effects of Ecstasy. | Q35095703 |
| | A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) | Q35851128 |
| | Neural systems recruited by drug- and food-related cues: studies of gene activation in corticolimbic regions | Q36247673 |
| | NMDA receptors and schizophrenia. | Q36650010 |
| | Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study | Q38449414 |
| | Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation | Q41103770 |
| | Schizophrenia and glutamatergic transmission | Q41690988 |
| | Glutamate receptors in the mammalian central nervous system | Q41742131 |
| | Effects of chronic ethanol treatment on the expression of calcium transport carriers and NMDA/glutamate receptor proteins in brain synaptic membranes. | Q42445259 |
| | Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain | Q42628774 |
| | Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. | Q43819999 |
| | Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). | Q43832354 |
| | Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog | Q43953511 |
| | Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. | Q44566036 |
| | NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment | Q44777830 |
| | Chronic MDMA (ecstasy) use, cognition and mood. | Q44847050 |
| | Psychedelic drugs: the ups and downs of ecstasy | Q44894621 |
| | Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users | Q45062249 |
| | Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period | Q45176326 |
| | Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. | Q46489637 |
| | Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits | Q46695931 |
| | The neurochemical circuitry of schizophrenia | Q46969572 |
| | Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization | Q48198206 |
| | Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment | Q48284067 |
| | Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo | Q48342256 |
| | The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine | Q48408450 |
| | Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain | Q48479239 |
| | Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia | Q48538394 |
| | Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine | Q48932688 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | teenager | Q1492760 |
| P304 | page(s) | 39 | |
| P577 | publication date | 2008-04-17 | |
| P1433 | published in | BMC Neuroscience | Q15766477 |
| P1476 | title | Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats | |
| P478 | volume | 9 | |